National Comprehensive Cancer Network

About NCCN

Leadership

• Board of Directors
• NCCN Foundation Board of Directors
• Management Team

Board of Directors

The NCCN Board of Directors is comprised of two representatives from each NCCN Member Institution who share in NCCN's mission to improve the quality and effectiveness of care provided to patients whom they serve.

---

Samuel M. Silver, MD, PhD / Chair
University of Michigan Comprehensive Cancer Center

Timothy J. Eberlein, MD / Vice Chair
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

Ray Lynch, CPA, MBA / Treasurer
Huntsman Cancer Institute at the University of Utah

Mara G. Bloom, JD, MS / Secretary
Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center

Laura L. Adams
Stanford Cancer Institute

Al B. Benson III, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Douglas W. Blayney, MD
Stanford Cancer Institute

Carolyn C. Carpenter, MHA
Duke Cancer Institute

Peter R. Carroll, MD
UCSF Helen Diller Family Comprehensive Cancer Center

William E. Carson III, MD
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

Peter F. Coccia, MD
UNMC Eppley Cancer Center at The Nebraska Medical Center

Thomas A. D'Amico, MD
Duke Cancer Institute

Stephen B. Edge, MD
Roswell Park Cancer Institute

Paul F. Engstrom, MD, FACP
Fox Chase Cancer Center

David S. Ettinger, MD
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Lauren E. Hackett, MPA
Vanderbilt-Ingram Cancer Center

David C. Hohn, MD
Roswell Park Cancer Institute

Mark F. Kochevar, MBA
University of Colorado Cancer Center

Larry E. Kun, MD
St. Jude Children's Research Hospital/The University of Tennessee Health Science Center

Razelle Kurzrock, MD
UC San Diego Moores Cancer Center

Terry S. Langbaum, MAS
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

G. Douglas Letson, MD
Moffitt Cancer Center

Harlan Levine, MD
City of Hope Comprehensive Cancer Center

Scott M. Lippman, MD
UC San Diego Moores Cancer Center

Trisha Lollo, MPH
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

Paul J. Nelson, MBA
Memorial Sloan-Kettering Cancer Center

Michael N. Neuss, MD
Vanderbilt-Ingram Cancer Center

Patrick J. O`Brien, MBA
Fox Chase Cancer Center

David G. Pfister, MD
Memorial Sloan-Kettering Cancer Center

Rita Potter
UNMC Eppley Cancer Center at The Nebraska Medical Center

Dorothy E. Puhy, MBA
Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center

Marty Sargeant, MBA
City of Hope Comprehensive Cancer Center

Lee S. Schwartzberg, MD, FACP
St. Jude Children's Research Hospital/The University of Tennessee Health Science Center

Gerrie Shields, MBA
UCSF Helen Diller Family Comprehensive Cancer Center

Warren Smedley, MSHA
University of Alabama at Birmingham Comprehensive Cancer Center

F. Marc Stewart, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

John W. Sweetenham, MD
Huntsman Cancer Institute at the University of Utah

Myra Tanita
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

The Honorable Ellen O. Tauscher
Chair, NCCN Foundation Board of Directors

Dan Theodorescu, MD, PhD
University of Colorado Cancer Center

William P. Vaughan, MD, MBA
University of Alabama at Birmingham Comprehensive Cancer Center

Braulio Vicente, Jr., MBA
Moffitt Cancer Center

Timothy E. Volpe, MSW
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Marcy B. Waldinger, MHSA
University of Michigan Comprehensive Cancer Center

Jeff A. Walker, MBA
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

Ronald S. Walters, MD, MS, MBA
The University of Texas MD Anderson Cancer Center

Randal S. Weber, MD
The University of Texas MD Anderson Cancer Center

 

---

NCCN Foundation Board of Directors

---

The Honorable Ellen O. Tauscher / Chair
Baker, Donelson, Bearman, Caldwell & Berkowitz, PC
Former Under Secretary of State for Arms Control & International Security and
Member of Congress

Michael Parisi, MBA, MS / Vice Chair
Ogilvy CommonHealth Worldwide

Ray Lynch, CPA, MBA / Treasurer
Huntsman Cancer Institute at the University of Utah

John A. Gentile, Jr. / Secretary
Harborside Press, LLC

Sam Donaldson / Chair Emeritus
ABC News

Al B. Benson III, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Joshua H. Bilenker, MD
Aisling Capital, LLC

Russell W. Budd, JD
Baron & Budd, P.C.

Gena Cook
Navigating Cancer

Thomas A. D'Amico, MD
Duke Cancer Institute

Brian Garofalo
Patient Alliances

John S. Greene
Salesforce.com

William N. Hait, MD, PhD
Janssen Research & Development, LLC
Johnson & Johnson Pharmaceuticals Group

Deborah Morosini, MD
Pathology Consultant

Denise Reinke, MS, NP
University of Michigan Comprehensive Cancer Center
Sarcoma Alliance for Research through Collaboration (SARC)

Andrew von Eschenbach, MD
Samaritan Health Initiatives
Former Commissioner of the US Food and Drug Administration and
Director of the National Cancer Institute

Robert C. Young, MD
RCY Medicine
Former President, Chief Executive Officer and Chancellor
of Fox Chase Cancer Center

---

Management Team

---

Robert W. Carlson, MD, is the Chief Executive Officer (CEO) at the National Comprehensive Cancer Network (NCCN). He joined NCCN as CEO in January 2013 following an esteemed history of leadership positions within the organization including, most notably, Representative to the NCCN Board of Directors, Chair of the Breast Cancer Guidelines Panel, Member and Founding Chair of the Breast Cancer Risk Reduction Guidelines Panel, and Chair of the Survivorship Guidelines Panel.

Prior to his appointment as CEO at NCCN, Dr. Carlson served as Professor of Medicine in the Division of Oncology and Stanford Medical Informatics at Stanford University Medical Center, as well as Medical Director of inpatient oncology and hematology at Stanford Cancer Institute in Stanford, California.

Dr. Carlson is a graduate of Stanford University Medical School, and he completed his internship and junior residency in internal medicine at Barnes Hospital Group in St. Louis, Missouri before returning to Stanford University to complete his senior residency. He earned a Bachelor of Science with distinction from Stanford University, specializing in biological sciences. Dr. Carlson is board certified in Medical Oncology and Internal Medicine.

Dr. Carlson is a member of several medical societies, including American College of Physicians (ACP), American Association for Cancer Research (AACR), and the American Society of Clinical Oncology (ASCO). Dr. Carlson lectures extensively and has authored or co-authored more than 140 articles, abstracts, and book chapters, which have appeared in publications such as Journal of the National Cancer Institute, Journal of Clinical Oncology, and The Breast Journal. He has served as Associate Editor of Oncology and JNCCN — Journal of the National Comprehensive Cancer Network.

From 2001 to 2012, Dr. Carlson was selected by America’s Top Doctors; from 1994 to 2011, he was selected by Best Doctors in America; in 2008, he was presented with the National Physician of the Year Award for Clinical Excellence by Castle Connolly Medical, Ltd.; and in 2010, Dr. Carlson was given the Founding Collaborator Award by the Breast Health Global Initiative (BHGI).

---

Patricia J. Goldsmith is Executive Vice President/Chief Operating Officer at the National Comprehensive Cancer Network (NCCN). In this role, Ms. Goldsmith is responsible for the overall operations of NCCN. She reports directly to the Chief Executive Officer and provides oversight of the functions of NCCN Oncology Outcomes Database, NCCN Oncology Research Program, Finance, U.S. & Global Business Development, Marketing and Communications, Public Affairs, Professional Publications, Best Practices, Analytics, Research & Consulting, Conferences and Meeting Planning, Media Programs, Continuing Medical Education and Grants, and Information Technology. In addition, she is responsible for public policy initiatives at the Federal level and national initiatives related to payors and employers including the education related to these constituencies. Ms. Goldsmith is also responsible for the NCCN Foundation, established as the philanthropic affiliate of NCCN to embrace the NCCN mission of improving the quality and effectiveness of care provided to patients with cancer.

Ms. Goldsmith formerly served as Vice President for Institutional Development, Public Affairs and Marketing at the Moffitt Cancer Center in Tampa, Florida – an NCCN Member Institution. There she oversaw the Moffitt Cancer Center's Foundation, Public Relations, Marketing, and Business Development functions in addition to Fundraising initiatives. Before joining Moffitt, she developed and directed all managed care activities for the University of South Florida College of Medicine.

A frequent speaker at national meetings and symposia, Ms. Goldsmith was chosen by U.S. Representative Bill McCollum (R-Fl.) in 2003 to join a panel of 100 thought leaders representing every stakeholder interest in health care. This unique effort focused on building consensus about what structural changes could be made in our nation's health care delivery system to assure quality health care for future generations.

Ms. Goldsmith has studied at the Pennsylvania State University, the University of Missouri Bloch School of Business and the Harvard School of Public Health. She was a winner of the 1999 Distinguished Women in Business Award sponsored by the Business Journal of Tampa Bay and also was named the 1999 Leukemia Society Woman of the Year, an award based on her philanthropic efforts on behalf of the Leukemia Society.

---

Lisa G. Kimbro, CPA, MBA, is Senior Vice President, Finance/Chief Financial Officer for the National Comprehensive Cancer Network (NCCN). In this role, Ms. Kimbro manages NCCN's financial and business initiatives as well as provides leadership to its NCCN Best Practices Committee.

Ms. Kimbro has extensive experience in both academic and community-based health care. She served as Director of Managed Care for the University of South Florida Physicians Group, where she was actively involved in the organization's strategic planning initiatives and feasibility studies. In the community setting, she was the CFO of two dynamic and well-regarded physician groups in the Tampa Bay area. The responsibilities for those practices included (among others) business development, managed care contracting, financial reporting, patient accounting, compliance initiatives, and personnel management.

In addition to Ms. Kimbro's healthcare experience, she has worked in public accounting, most recently with Ernst & Young Global as a senior manager in Quality and Risk Management in its Paris, France office.

Ms. Kimbro completed her master's in Business Administration at the University of South Florida and her undergraduate degree at Florida State University. She is the co-author of the Governmental Accounting Standards Board Research Report, “The Needs of Users of Governmental Financial Reports.”

---

Joan S. McClure, MS, is Senior Vice President of Clinical Information and Publications for the National Comprehensive Cancer Network (NCCN). Ms. McClure is responsible for the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®), the NCCN Drugs & Biologics Compendium (NCCN Compendium^®), NCCN Information Technology, and JNCCN — Journal of the National Comprehensive Cancer Network. Ms. McClure also serves as an Associate Editor for JNCCN. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) are a comprehensive set of guidelines detailing the sequential management decisions and interventions for the malignant cancers that affect 95% of all patients with cancer and for cancer prevention, screening, diagnosis and supportive care. Updated continuously, the NCCN Guidelines are recognized as the standard for clinical policy in the United States and have served as a model for guidelines programs elsewhere in the world.

Ms. McClure previously managed national oncology information programs for patients, health professionals and the public on contracts with the U. S. National Cancer Institute (NCI). She directed investigator and patient recruitment efforts in oncology for a multinational contract research organization where she also managed the technical and scientific effort to identify and develop standards for medical and toxicology data for submission to regulatory authorities in the United States, Europe, and Japan in a contract with the U.S. Food and Drug Administration (FDA). She supported NCI's Cancer Therapy Evaluation Program in its 2000 revision of the Common Toxicity Criteria (CTC).

---

C. Lyn Fitzgerald, MJ, is Vice President, U.S. & Global Development at the National Comprehensive Cancer Network (NCCN). In this role, Ms. Fitzgerald is charged with the development of U.S. and International business strategies. She serves as the key contact for Industry and oversees the NCCN Corporate Council and all permissions and licensing of NCCN content for commercial use.  Additionally, Ms. Fitzgerald provides oversight of the NCCN Communications & Marketing functions, the NCCN Academy for Excellence & Leadership in Oncology™ School of Pharmaceutical & Biotech Business, and NCCN Business Insights offerings, including:  NCCN Trends™, NCCN Oncology Insights Reports™, and NCCN Flash Updates™.

Prior to joining NCCN, Ms. Fitzgerald was a member of the Business Development team at the Nemours/Alfred I DuPont Hospital for Children, where she worked to develop and advance communication strategies for building and maintaining provider relationships. Ms. Fitzgerald was responsible for professional relations, including physician advocacy, and served as liaison to Nemours partner hospitals and to community practices, including providing educational programming and support.

From 1995 to 2001, Ms. Fitzgerald served as a Key Specialty Senior Representative at Schering-Plough Pharmaceuticals. Ms. Fitzgerald is a two-time Temple University graduate, earning a Bachelor of Business Administration in Economics from the Fox School of Business and a Master of Journalism from the School of Communications.  She is a published author of multiple articles on health and health care policy. 

---

Kristina M. Gregory, RN, MSN, OCN, is Vice President of Clinical Information Operations at the National Comprehensive Cancer Network (NCCN). In this role, Ms. Gregory is responsible for production of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®). She also monitors and maintains tracking schedules representing the status of the NCCN Guidelines in the development process and web publication. Ms. Gregory also oversees production of NCCN Programs affiliated with the NCCN Guidelines^®, including the NCCN Compendium^® and NCCN Templates^®.

Prior to working with NCCN, Ms. Gregory served as a Health Management Program Coordinator at Independence Blue Cross in Philadelphia, PA and was also a staff nurse at Fox Chase Cancer Center. Ms. Gregory is an active member of the National and Bucks/Montgomery Counties Chapter of the Oncology Nursing Society (ONS), the American Society of Clinical Oncology (ASCO), and a volunteer for the Leukemia and Lymphoma Society.

Ms. Gregory has a master's degree in Public Health Nursing from LaSalle University, and a B.S. in Nursing from the University of Pennsylvania. She is also a certified oncology nurse.

---

Diane E. Paul, MS, RN, is Vice President of the Oncology Research Program at the National Comprehensive Cancer Network (NCCN). In this role, Ms. Paul is responsible for developing and managing NCCN's centralized, standardized infrastructure for the conduct of clinical trials among its 23 NCCN Member Institutions. The Oncology Research Program fosters collaboration among NCCN Member Institutions and pharmaceutical and biotechnology companies to bring promising and effective new treatments to patients with cancer.

Prior to working with NCCN, Ms. Paul served as Executive Director of the Cancer Institute of New Jersey Oncology Group, and Director of the Cancer Institute of New Jersey Network at the University of Medicine and Dentistry of New Jersey in New Brunswick, New Jersey. Ms. Paul speaks often on such topics as cancer screenings and prevention and has published articles in clinical publications including Cancer Investigation, Cancer Practice, and Oncology Nursing Forum.

For her work with the Cancer Hope Network, Ms. Paul received an “Unsung Heroine Award” in 1988 – an honor sponsored by the Women's Network of New Jersey and presented by Senator Bill Bradley. She also received the Information Service Partnership Award from the National Cancer Institute in 1996. She is a recipient of Coping magazine's Hero Award and Mirabella's “1000 Points of Light” Award.

Ms. Paul completed her undergraduate degree in Nursing Science at the College of Saint Elizabeth in Convent Station, New Jersey, and her master's degree in Psychiatric/Mental Health Nursing at Rutgers University. She is a member of the Association of Cancer Executives, the American Society of Clinical Oncology and the Oncology Nursing Society.